Company profile
Henry Schein, Inc.
NASDAQ: HSIC · Healthcare · Medical - Distribution
#35 of 1,418 Healthcare companies by revenue47th-percentile growth
EA Score
77B+FH 79DQ 79GM 59SS 94
v0.1 · 65/100 weight · provisional
↑ workforce scale, market scale · ↓ 3-yr revenue growth, revenue growth (YoY)
Methodology →Revenue TTM
$13.4B
Rev growth YoY (TTM)
+5.6%
Net income (FY)
$398.0M
Employees
25,000
as of 2026-08-06
Market cap
$10.2B
as of 2026-08-06
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$13.2B$13.2B2025
Net income$398.0M$398.0M2025
Operating income$653.0M$653.0M2025
Total assets$11.2B$11.2B2025
Liabilities$6.4B$6.4B2025
Equity$3.2B$3.2B2025
Revenue trend
FY2020 – FY2025 · USD
FY20
FY20
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Henry Schein, Inc.’s revenue?
Henry Schein, Inc. booked $13.2B in FY2025 revenue, growing 4.0% year over year — about the middle of the pack among Healthcare companies we track, at a 3.0% net margin.
Peers · Healthcare
Viatris Inc.63CLabcorp Holdings Inc.84B+DaVita Inc.77B+BrightSpring Health Services, Inc. Common Stock69BCommunity Health Systems, Inc.74BVertex Pharmaceuticals Incorporated88ANeighbors
Suffolk →Key facts
CEOFrederick Lowery
SectorHealthcare
IndustryMedical - Distribution
HeadquartersMelville, NY
ExchangeNASDAQ: HSIC
Employees25,000
IPO date1995-11-03
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.